Meniscus allografts: How to improve clinical results, limit chondral degeneration?
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Pujol, N. | - |
dc.contributor.author | Lipinski, L. | - |
dc.contributor.author | Kim, S.H. | - |
dc.date.accessioned | 2024-01-09T13:37:02Z | - |
dc.date.available | 2024-01-09T13:37:02Z | - |
dc.date.issued | 2020-04 | - |
dc.identifier.issn | 0000-0000 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/70299 | - |
dc.description.abstract | Meniscus injury is the most frequent injury of the knee. Despite the increasing knowledge of the meniscus pathology and the importance of repairing repairable lesions, meniscectomy is still a way of treatment in symptomatic knee [1]. Meniscus allograft transplantation (MAT) is a favorable option in patients with a painful knee after a meniscectomy. It provides good improvements in function and symptoms [2]. © ESSKA 2020. | - |
dc.format.extent | 5 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Springer Berlin Heidelberg | - |
dc.title | Meniscus allografts: How to improve clinical results, limit chondral degeneration? | - |
dc.type | Article | - |
dc.identifier.doi | 10.1007/978-3-662-61264-4_1 | - |
dc.identifier.bibliographicCitation | ESSKA Instructional Course Lecture Book: Milan 2021, pp 1 - 5 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.scopusid | 2-s2.0-85088474522 | - |
dc.citation.endPage | 5 | - |
dc.citation.startPage | 1 | - |
dc.citation.title | ESSKA Instructional Course Lecture Book: Milan 2021 | - |
dc.type.docType | Book Chapter | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.